MagForce AG Publishes First Quarterly Shareholder Letter
(Thomson Reuters ONE) -
MagForce AG /
MagForce AG Publishes First Quarterly Shareholder Letter
. Ad hoc announcement according to § 15 WpHG. Processed and transmitted by Thomson Reuters ONE.
The issuer is solely responsible for the content of this announcement.
Berlin, Germany, July 24, 2013 - MagForce AG (Frankfurt, Xetra: MF6), a leading
medical device company in the area of nanotechnology with a focus on oncology,
published today its first "Shareholder Letter".
Subsequently, such shareholder letters shall be published quarterly in order to
keep shareholders well informed about the ongoing developments and progress.
The shareholder letter can be downloaded here:
http://www.magforce.de/en/presse-investoren/aktionaersbriefe.html
Key points are
* Personal introduction of Dr. Ben Lipps, designated CEO and Chairman of the
Management Board
* Focus on recurrent Glioblastoma Multiform Cancer (GBM) and Prostate Cancer
* Details to GBM post-marketing study
* Search for strategic partners in Emerging Markets.
About MagForce AG
MagForce AG is a leading medical device company in the field of nanomedicine in
oncology, listed in the entry standard (MF6). The Company's proprietary,
NanoTherm(®) therapy, enables the targeted treatment of solid tumors through the
intratumoral generation of heat via activation of superparamagnetic
nanoparticles. NanoTherm(®), NanoPlan(®), and NanoActivator(TM) are components
of the therapy and have received EU-wide regulatory approval as medical devices
for the treatment of brain tumors. MagForce, NanoTherm(®), NanoPlan(®), and
NanoActivator(TM) are trademarks of MagForce AG in selected countries. For more
information, please visit www.magforce.com.
Full Resume Dr. Ben Lipps
Dr. Ben J. Lipps became Chairman and Chief Executive Officer of the Management
Board of Fresenius Medical Care in May 1999. In December 2012 he stepped down as
Chairman of the Management Board and CEO. During his term, Fresenius Medical
Care's sales tripled from 3.8 to 12.8 billion dollars, and the annual net profit
grew 6 times to 1.1 billion dollars.
He was also Chief Executive Officer of Fresenius Medical Care North America
until February 2004. He was President, Chief Executive Officer, Chief Operating
Officer and a director of Fresenius USA from October 1989 through February
2004, and served in various capacities with Fresenius USA's predecessor from
1985 through 1989.
He earned his master's and doctoral degrees at the Massachusetts Institute of
Technology in chemical engineering. Before joining the Fresenius Group in 1985,
Dr. Lipps held several research management positions in various companies, among
them with DOW Chemical.
Disclaimer
This release may contain forward-looking statements and information which may be
identified by formulations using terms such as "expects", "aims", "anticipates",
"intends", "plans", "believes", "seeks", "estimates" or "will". Such forward-
looking statements are based on our current expectations and certain
assumptions, which may be subject to a variety of risks and uncertainties. The
results actually achieved by MagForce AG may substantially differ from these
forward-looking statements. MagForce AG assumes no obligation to update these
forward-looking statements or to correct them in case of developments, which
differ from those, anticipated.
Contact:
Anne Hennecke
MC Services AG
T +49 89 210228-18
F +49 89 210228-88
M +49 151 12 555 759
Email: anne.hennecke(at)mc-services.eu
MagForce_Press Release_July 24, 2013:
http://hugin.info/143761/R/1718378/571584.pdf
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: MagForce AG via Thomson Reuters ONE
[HUG#1718378]
Unternehmensinformation / Kurzprofil:
Datum: 24.07.2013 - 11:56 Uhr
Sprache: Deutsch
News-ID 281412
Anzahl Zeichen: 4655
contact information:
Town:
Berlin
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 188 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"MagForce AG Publishes First Quarterly Shareholder Letter"
steht unter der journalistisch-redaktionellen Verantwortung von
MagForce AG (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
